高级检索
当前位置: 首页 > 详情页

TRIM59 is a key regulator of growth and migration inrenal cell carcinoma

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Clinical Laboratory, Affiliated Hospital of Dali University, Dali, China [2]Clinical research center of Occupational disease, Shanghai Pulmonary Hospital,Tongji University School of Medicine, Shanghai, China [3]Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China [4]Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China [5]Department of Radiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
出处:
ISSN:

关键词: TRIM59 Growth Migration Invasion Renal cell carcinoma

摘要:
Renal cell carcinoma (RCC) is the most common renal neoplasms and metastatic is common. Previous data have shown that the tripartite motif (TRIM) family proteinswere implicated in human tumoriogenesis. In this study, we aimed to investigate the role of TRIM59 in the cell growth and migration in RCC. The expression of TRIM59 in human RCC tissues was initially examined by qRT-PCR. Alentivirus-based shRNA against TRIM59 (Lv-shTRIM59) was constructed. The effects of TRIM59 knockdown on cell proliferation were examined by in vitro MTT assay, colony formation assay and in vivo a mouse xenograft model of RCC. Cell migration and invasion after knockdown of TRIM59 were also examined by transwell assay. Our data showed that the mRNA level of TRIM59 in cancerous tissues was 2-fold increased as compared with non-cancerous tissues. Knockdown of TRIM59 in a RCC cell line 786-O significantly slowed down cell proliferative rate and decreased both the colony number and sizes. In the mouse model, knockdown of TRIM59 consistently inhibited tumor growth in vivo. Moreover, it was shown that cell migration and invasion were suppressed by 68% and 50%, respectively in TRIM59-depleted 786-O cells. Our data suggest that TRIM59 may serve as a pro-oncogenic protein in promoting the progression of RCC. Knockdown of TRIM59 may be a promising strategy concerning the early detection and treatment of RCC.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2017]版:
大类 | 4 区 生物
小类 | 4 区 生化与分子生物学 4 区 细胞生物学
最新[2025]版:
JCR分区:
出版当年[2017]版:
Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Q4 CELL BIOLOGY
最新[2023]版:
Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Q4 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Clinical Laboratory, Affiliated Hospital of Dali University, Dali, China
共同第一作者:
通讯作者:
通讯机构: [5]Department of Radiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号